BGM-2102

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameBGM-2102
Drug Alias NameBGM2102BGM-2102BGM-0504/BGM-1812BGM0504/BGM1812
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsCalcitonin receptor agonists +[4] 
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorCalcitonin receptor +[4] 
Therapy Area/IndicationsOverweight
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes BGM-0504BGM-1812
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBrightgene Bio-Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrightgene Bio-Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweight
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A